Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Icy Hot Marketer Goes Cold for Analyst - Happi
Company News

Icy Hot Marketer Goes Cold for Analyst

Chattem gets a downgrade on lower sales projections.

A Jefferies & Co. analyst downgraded shares of toiletries and dietary supplements maker Chattem Inc. Wednesday, citing concerns over a slowdown in sales.

Jefferies analyst Douglas M. Lane cut his rating on the stock to “Hold” from “Buy” and reaffirmed a price target of $72. In a note to clients, he wrote sales seem to have fallen in June.

“This compels us to reduce estimates, and with the stock within 8 percent of our target, to move to the sidelines pending reacceleration of point-of-sales,” he wrote in a note to investors.

Lane’s price target on Chattem shares is $72. The stock finished Tuesday’s trading at $65.90.

Lane also cut his fiscal 2009 earnings-per-share outlook to $4.50 from $4.60.

Chattanooga, Tenn.-based Chattem’s products include medicated skin care products such as Gold Bond, Cortizone-10, and Balmex, along with topical pain products Icy Hot and Aspercreme. It also makes the medicated dandruff shampoo Selsun Blue and dietary supplements.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters